Portfolio news 0

Diurnal Group plc

Directorate Changes

Carisma Therapeutics Inc.

Carisma Therapeutics Presents Data from Phase I Clinical Trial of CT-0508, A HER2 Targeted CAR-Macrophage

Oxford Nanopore Technologies plc

Update to revenue guidance following expansion of customer project

Actual Experience plc

Two New Contract Wins

Hinge Health

Hinge Health reaches $6.2 billion valuation and has more than doubled its customer base YoY to over 575 enterprise customers

MOBILion Systems

Pennsylvania science start-up MOBILion Systems extends successful launch of new technology

Mirriad Advertising plc

Mirriad hires music industry veterans

DeepMatter Group plc

Appointment of new Scientific Advisory Board

DeepMatter Group Plc

To trial its DigitalGlassware® platform with Aurigene Pharmaceutical Services

Crescendo Biologics Ltd

Crescendo Biologics announces prestigious new collaboration with The Institute of Cancer Research, London